Bueno and colleagues published this meta-analysis in the British Journal of Nutrition in 2013, pooling data from 13 randomized controlled trials that directly compared very-low-carbohydrate ketogenic diets (less than 50 grams of carbs per day) to low-fat diets (less than 30% of calories from fat) for weight loss.

At 12 months or longer follow-up, ketogenic dieters lost an additional 0.9 kg compared to low-fat dieters. This was statistically significant. The ketogenic diet also produced greater improvements in triglycerides (blood fats dropped by an additional 0.18 mmol/L), HDL cholesterol (the "good" cholesterol rose by an additional 0.09 mmol/L), and blood pressure (diastolic dropped by an additional 1.43 mmHg).

While 0.9 kg may sound small, it represents the additional benefit over an already effective low-fat diet. Both groups lost substantial weight - the ketogenic diet simply produced more weight loss. The metabolic improvements are also clinically meaningful, suggesting the ketogenic diet may offer cardiovascular benefits beyond just weight reduction.

Yancy and colleagues published this randomized controlled trial in Annals of Internal Medicine in 2004. They assigned 120 overweight adults with high cholesterol to either a low-carbohydrate ketogenic diet (less than 20 grams of carbs per day) or a low-fat diet (less than 30% of calories from fat, with calorie restriction).

At 24 weeks, the ketogenic diet group lost significantly more weight than the low-fat group. The ketogenic group also had better retention - more participants stuck with the diet and completed the study. This is important because any diet only works if people can actually follow it.

Triglyceride levels decreased more in the ketogenic group, and HDL cholesterol increased more. LDL cholesterol also increased in the ketogenic group, which is a common concern with high-fat diets. The study demonstrated that a low-carbohydrate approach can produce superior weight loss with acceptable adherence compared to conventional low-fat dietary advice.

Dashti and colleagues published this study in Experimental and Clinical Cardiology in 2004. They followed 83 obese patients (39 men and 44 women) with a body mass index greater than 35 who were placed on a ketogenic diet consisting of 30 grams of carbohydrates, 1 gram of protein per kilogram of body weight, and 20% of calories from saturated fat.

After 24 weeks, the results were substantial. Body weight decreased by an average of 12.8 kg. BMI dropped from 37.8 to 33.1. Blood glucose decreased from 101 to 93 mg/dL. Total cholesterol dropped by about 30 mg/dL, and triglycerides decreased from 224 to 147 mg/dL. HDL cholesterol increased significantly while LDL cholesterol decreased.

The researchers noted that these changes occurred without significant adverse effects. Kidney and liver function tests remained normal throughout the study. This study is one of the longer-duration investigations of the ketogenic diet in clinical practice and suggests that sustained ketogenic dieting can produce and maintain meaningful weight loss over at least 6 months.

Dierkes and colleagues published this umbrella review in BMC Medicine in 2023, synthesizing findings from multiple systematic reviews and meta-analyses on the health effects of ketogenic diets. An umbrella review examines reviews rather than individual studies, providing a birds-eye view of the entire evidence base.

Across the pooled meta-analyses, ketogenic diets consistently produced greater weight loss than comparison diets. The certainty of evidence for weight loss was rated as high for short-to-medium-term outcomes (up to 12 months). The effect was most pronounced in the first 6 months and diminished somewhat over longer follow-up periods.

The review also found benefits for blood sugar control, triglyceride reduction, and HDL cholesterol improvement. These metabolic improvements are clinically relevant because they reduce the risk of heart disease and type 2 diabetes - conditions closely linked to obesity.

Choi and colleagues published this meta-analysis in Nutrients in 2020, focusing specifically on metabolic outcomes of ketogenic diets in people with overweight, obesity, or type 2 diabetes. They analyzed randomized controlled trials lasting from 4 weeks to 12 months.

The mean post-intervention weight change was -7.78 kg in diabetic patients and -3.81 kg in the overall pooled population compared to control diets. The larger effect in diabetic patients may reflect the particular metabolic advantage of carbohydrate restriction when the body has impaired ability to process carbohydrates.

The ketogenic diet also improved fasting blood sugar, HbA1c (a measure of average blood sugar over 3 months), and triglycerides. These benefits are especially important for people with type 2 diabetes, where weight loss directly improves the underlying metabolic dysfunction.

Castellana and colleagues published this systematic review and meta-analysis in Reviews in Endocrine and Metabolic Disorders in 2019, examining very-low-calorie ketogenic diets (VLCKDs) that combine ketosis with caloric restriction (typically under 800 calories per day).

The pooled results showed substantial weight losses ranging from 10.0 to 15.6 kg across studies. Crucially, the weight lost during the active ketogenic phase was maintained at follow-up assessments conducted up to 2 years after the initial diet period. This challenges the common criticism that keto weight loss is temporary.

The maintenance of weight loss may be partly explained by the diet''s effect on appetite hormones. Ketosis has been shown to suppress ghrelin (the hunger hormone) and increase satiety, which could help people maintain their new weight even after transitioning off strict ketosis. The very-low-calorie approach adds initial rapid weight loss that may serve as motivation for continued dietary compliance.

This meta-analysis published in the Journal of Human Nutrition and Dietetics in 2021 focused specifically on body composition changes - not just total weight, but what kind of weight was lost. They analyzed randomized controlled trials that measured fat mass and lean mass separately using body composition assessment methods.

The ketogenic diet groups showed significant reductions in total body weight, fat mass, and BMI compared to comparison diets. Importantly, lean body mass (muscle) was relatively preserved, meaning most of the weight lost came from fat rather than muscle.

This is a critical distinction because many diets cause substantial muscle loss along with fat loss, which can lower metabolic rate and make weight regain more likely. If the ketogenic diet preferentially burns fat while sparing muscle, it may offer a better quality of weight loss that is more sustainable in the long term.

Patikorn and colleagues published this umbrella review in the Journal of Clinical Endocrinology and Metabolism in 2023. The review synthesized evidence from 17 meta-analyses covering multiple outcomes related to ketogenic diets in overweight and obese populations.

The review found consistent evidence that ketogenic diets reduce body weight, waist circumference, body fat percentage, blood sugar, insulin levels, triglycerides, and blood pressure. The weight loss findings were supported by multiple independent meta-analyses, increasing confidence in the result.

The authors noted that the quality of evidence varied by outcome, with weight loss having the strongest and most consistent support. They also acknowledged that most trials were relatively short (under 12 months) and that more long-term data would strengthen the conclusions.

Yuan and colleagues published this systematic review and meta-analysis in Nutrition and Metabolism in 2020, analyzing randomized controlled trials that compared ketogenic diets to other dietary approaches in people with type 2 diabetes. This population is particularly relevant because weight loss is a primary treatment goal for type 2 diabetes.

Ketogenic diets produced significantly greater reductions in body weight, HbA1c (a 3-month average of blood sugar), and triglycerides compared to control diets. The improvements in blood sugar control are especially meaningful because better glucose management in diabetes directly reduces the risk of complications including nerve damage, kidney disease, and vision loss.

The benefits persisted at 12-month follow-up in studies with longer observation periods, suggesting that for diabetic patients who can maintain the diet, the ketogenic approach offers sustained advantages over conventional dietary advice.

This pragmatic randomized controlled trial published in Obesity in January 2025 compared a "healthy ketogenic diet" (emphasizing whole foods and healthy fats) to a conventional energy-restricted diet in adults with obesity over a multi-month intervention period.

The ketogenic group achieved greater weight loss despite not being required to restrict calories to the same degree as the comparison group. This finding supports the hypothesis that ketogenic diets may have metabolic advantages beyond calorie reduction alone - possibly through increased fat burning, appetite suppression from ketosis, or the thermic effect of high protein intake.

As a pragmatic trial, it tested the diets under real-world conditions rather than tightly controlled laboratory settings. This makes the results more applicable to how people would actually use these diets in everyday life, where strict calorie counting is often impractical.